Top U.S. Pharmacies To Offer Abortion Pill After FDA Loosens Regulations— What Could Possibly Go Wrong?

5Mind. The Meme Platform
Cameron Keegan: Dear Rest Of America Header

Imagine walking into a local CVS and Walgreens to pick up a snack or Advil, and alongside you, a pregnant woman might be collecting prescribed drugs to kill her growing yet unborn child.

Once the Food and Drug Administration (FDA) loosened its “abortion pill” distribution regulations, it was only a matter of time before top U.S. drugstore chains announced plans to dispense drugs that end unborn lives within the first ten weeks of pregnancies.

Initially, the FDA announced it would lift longstanding restrictions on “abortion pills” in December 2021, allowing physicians to prescribe such killer drugs and have them dispatched directly to patients or sent to a local pharmacy.

Fast forward to early January 2023, and the FDA updated its guidelines to allow pharmacies outside a medical facility to dispense mifepristone—a drug that, when used alongside misoprostol, would end preborn lives during the earliest phase of pregnancy—thus widening abortion access in states where the act remains legal.

Soon after, Walgreens and CVS announced that their companies would undergo a certification process to gain approval for dispensing mifepristone. Both companies, which reign as the largest U.S. retail pharmacies, must complete a “Pharmacy Agreement Form” before being legally permitted to carry the lethal drug. In addition, according to The New York Times, CVS and Walgreens would distribute mifepristone in compliance with state and federal laws.

Making access to the drug as easy as possible

In the likely case that Walgreens and CVS obtain the certification, Americans shopping for everyday items like candy, Advil or Tylenol could soon be picking up drugs prescribed to end the lives of their unborn children.

Despite pregnant women still needing a prescription to access the lethal pill, the revised FDA guidelines provide them with the option of collecting the drug at their local pharmacy, thus adding a layer of convenience to the steps needed to stop a heartbeat in their womb.

Talking of convenience, the loosened regulations allow physicians to prescribe mifepristone via telemedicine without determining the stage of pregnancy or verifying whether the woman in question is pregnant in the first place.

Health risks for women who take mifepristone

An activist movement known as Students for Life of America (SFLA) has stressed that these “abortion pills” are also dangerous to women’s health, besides killing preborn human life. The SFLA had circulated a petition to “restore health and safety standards to chemical abortion pill regulations,” expressing that the FDA has intentionally ignored the health risks for women who take mifepristone.

Indeed, the FDA has previously linked the killer drugs to at least 24 women’s deaths and 4,000 serious complications in 2018. Meanwhile, the United Kingdom (U.K.) reportedly saw a spike in hospitalization rate after its government permitted similar drugs by mail in 2020. According to U.K. health data, over 10,000 women who received such drugs—that’s about one in 17 women—required hospital treatment in 2020.

Furthermore, dating as far back as 2009, a Finnish study published in “Obstetrics and Gynecology” revealed a complication rate of approximately 20 percent for “medical abortion” involving mifepristone compared to 5.6 percent for “surgical abortions,” after which hemorrhages and incomplete abortions were most commonly observed.

It must be stressed that the SFLA’s petition was rejected, and the group’s president Kristan Hawkins expressed the following in an early January press release:

“In a week in which we learn that [President] Biden’s FDA admits more women have died after taking Chemical Abortion Pills, they reject restoring health and safety standards designed to protect women. The FDA doesn’t seem to care who dies after taking Chemical Abortion pills, as long as a baby’s life is also ended.”

To what extent such activism in the form of demonstrations will impact women who are determined to take the life of their unborn child, who will ignore hooting and horns and head straight into that pharmacy store to collect mifepristone—remains to be seen.

States banning the dispensing of mifepristone

Given the overturning of Roe v. Wade, pharmacies across eighteen states are barred from dispensing mifepristone due to strict regulations on protecting unborn human life or because pregnant women can only collect the lethal drug directly from a physician. Moreover, several states, such as Missouri, could also proceed to ban the dispensing of mifepristone by mail delivery.

Furthermore, pro-life activists are vocalizing the suggestion of legal action against pharmacies that choose to dispense the drug amidst pending lawsuits seeking to ban their use across the United States.

Kristi Hamrick is the vice president of policy for SFLA. “If Walgreens wants to learn anything from more than 50 years of our abortion activism, it’s that we will not give up,” she said. “They should be concerned about the kind of liability they will face.”

Indeed, the updated guidelines by the FDA around mifepristone would require pharmacies to obtain additional certification. To this end, the American Pharmacists Association (APhA) and the National Community Pharmacists Association (NCPA) have expressed uncertainty about how many pharmacists will proceed through the further bureaucracy.

  • Ilisa Bernstein is the interim CEO of APhA. “The safety of pharmacy teams is really important, and that’s something they’re going to take into consideration when they decide whether or not to become certified,” she said. “In some communities, that may be more of a concern than others, but it is a concern.”
  • Ronna Hauser, the senior vice president of policy and pharmacy affairs for NCPA, expressed that individuals concerned with manufacturing, regulating and distributing mifepristone are attempting to “avoid a single database” containing patient and physician data.

It remains to be seen, albeit highly suspect, whether the amount needed to begin a medication abortion, around $75 for the average retail price of one mifepristone tablet, will deter women desperate to end a growing life from within themselves.

The battle to cherish unborn human life is, ultimately, a moral and spiritual battle. Many women may believe they are removing “a clump of cells.” And others may secretly know or even admit they are taking the life of their growing child.

As the late Andrew Breitbart stated, “politics is downstream of culture.”

Change the culture. Change the politics. Change the policies.

In fact, imagine a culture where the very act of “abortion” becomes almost redundant because women and their significant other are choosing to have and raise children within the bonds of a committed marital relationship.

Now that’s a totally radical idea, right?

By Cameron Keegan

Read Original Article On Dear Rest Of America

Contact Your Elected Officials
Right Wire Report
Right Wire Reporthttps://rightwirereport.com/
Right Wire Report was a group of concerned citizens who took action to promote traditional values and work for a better America.

Penny for your thoughts

The curtain fell quietly on a 232-year tradition as the U.S. Mint struck the last penny in Philadelphia. This ended one of the longest runs in American history.

The Rise of the Narcissist

Narcissism once applied to a handful of unusually self-absorbed individuals, but now seems to apply to an entire generation. How did we got here?

The ‘But Aluminum in Tea’ Vaxx Industry Lie, Debunked

Aluminum from injections (vaccines) is embedded into organs and tissues and exponentially outstrips the rate of absorption via consumption.

The $40 million mulligan

Virginia Tech drew attention by hiring James Franklin as its new coach, a surprising move given he was fired just over a month ago.

Seditious Silliness

A group of Democrats just posted a video in which they remind all US military personnel that they have the right to ignore "illegal" orders.

Rep. Marjorie Taylor Greene Says She’s Resigning From Congress

Rep. Marjorie Taylor Greene (R-Ga.) announced on Nov. 21 that she is resigning from Congress, with her resignation taking effect on Jan. 5, 2026.

Zoox Launches Pilot Program of Free Robotaxi Service in San Francisco

Zoox, Amazon’s robotaxi service, launched free rides in parts of San Francisco, moving closer to competing with Waymo in autonomous taxi services.

US Asks Embassies to Report Human Rights, Public Safety Impacts of Mass Migration

U.S. State Dept told embassies to report human rights and safety impacts of mass migration, labeling the movement a “human rights concern.”

Energy Dept Dismantles Major Biden-Era Offices, Shifts Focus to Nuclear, Fossil Fuels

U.S. Dept of Energy is dismantling key offices behind Biden-era fossil fuel transition in a major internal reorganization.

5 Takeaways From Trump’s Meeting With Mamdani

President Donald Trump welcomed newly elected New York City Mayor Zohran Mamdani to the White House on Nov. 21 to discuss plans for the city.

Trump, Mamdani Highlight Common Ground in White House Meeting

Trump and NYC Mayor-elect Mamdani had a “productive meeting” at the White House, finding common ground on housing and affordability issues.

Americans Can Expect $1,000 Bump in 2026 Tax Refunds: White House

According to a new study from Piper Sandler, which is out this week, tax filers can expect an extra $1,000 bump to their tax refund next year.

Trump Calls for ‘Federal Standard’ for AI, Stopping States From Creating Their Own Rules

Trump alleged that some states are trying to embed diversity, equity, and inclusion ideology into AI models, but did not specify which states or how.
spot_img

Related Articles

Popular Categories

MAGA Business Central